Total hypertension | ||||||
---|---|---|---|---|---|---|
 | Crude model | Model 1 | Model 2 | |||
 | OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value |
TyG index | 2.181 (1.924–2.472) | < 0.001 | 1.448 (1.256–1.670) | < 0.001 | 1.432 (1.215–1.688) | < 0.001 |
TG/HDL-C | 1.121 (1.088–1.155) | < 0.001 | 1.035 (1.008–1.062) | 0.01 | 1.024 (0.995–1.053) | 0.10 |
METS-IR | 6.778 (4.917–9.343) | < 0.001 | 1.769 (1.195–2.619) | 0.004 | 1.553 (1.040–2.321) | 0.03 |
ZJU index | 1.023 (1.018–1.029) | < 0.001 | 1.004 (0.999–1.009) | 0.08 | 1.003 (0.998–1.008) | 0.27 |
Stage I hypertension | ||||||
TyG index | 1.900 (1.654–2.182) | < 0.001 | 1.286 (1.096–1.510) | 0.002 | 1.292 (1.074–1.554) | 0.007 |
TG/HDL-C | 1.010 (1.066–1.136) | < 0.001 | 1.015 (0.983–1.049) | 0.35 | 1.007 (0.971–1.045) | 0.70 |
METS-IR | 5.143 (3.613–7.323) | < 0.001 | 1.360 (0.873–2.119) | 0.17 | 1.246 (0.789–1.968) | 0.34 |
ZJU index | 1.022 (1.016–1.027) | < 0.001 | 1.002 (0.996–1.007) | 0.58 | 1.001 (0.995–1.007) | 0.72 |
Stage II hypertension | ||||||
TyG index | 3.015 (2.492–3.647) | < 0.001 | 1.907 (1.530–2.375) | < 0.001 | 1.834 (1.403–2.397) | < 0.001 |
TG/HDL-C | 1.153 (1.113–1.195) | < 0.001 | 1.062 (1.027–1.097) | < 0.001 | 1.038 (1.000–1.078) | 0.053 |
METS-IR | 13.159 (8.053–21.502) | < 0.001 | 3.241 (1.752–5.994) | < 0.001 | 2.415 (1.275–4.573) | 0.007 |
ZJU index | 1.030 (1.023–1.036) | < 0.001 | 1.008 (1.002–1.014) | 0.008 | 1.005 (0.998–1.011) | 0.15 |